Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
durvalumab
Locations
1
South Korea
Severance Hospital
Seoul, South Korea
Start Date
February 12, 2019
Primary Completion Date
May 1, 2027
Completion Date
May 1, 2027
Last Updated
September 26, 2019
Lead Sponsor
Yonsei University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions